BETHESDA, MD. July 25, 2019 - BrainScope announced today that it has successfully completed a nearly five year, $9.9 million U.S. Department of Defense research contract supporting the development and validation of an objective marker of the ...
Athletes are critical to identifying head injury and concussion!
BrainScope Advances its Commercial Adoption and Appoints Industry Veteran Susan Hertzberg as CEO
Over 30% Reduction in Unnecessary Head CT Scans When Integrating FDA-Cleared BrainScope One
BrainScope Completes Large-Scale Clinical Studies of Concussion in Universities, High Schools and Concussion Clinics
BrainScope Announces Publication Describing Proprietary Concussion Biomarker to Assess Potential Severity and Predict Prolonged Recovery
As your student heads back to college, peace of mind should be at top of mind.
Traumatic brain injuries including concussion are among the most common and challenging diagnoses for a physician to make in an Emergency Department, especially in patients presenting with mild head injuries. BrainScope gives Emergency physicians ...
When patients hurt their heads, where do they go? Your urgent care can be an option. The revolutionary, EEG-based, BrainScope One head injury assessment device allows for assessment at the point of care. It provides economic value to your practice ...
The BrainScope system, utilizing Electroencephalogram (EEG) technology cleared by the FDA, is the first objective, adjunctive device capable of assessing the full spectrum of mild traumatic brain injury (mTBI). Its ability to rapidly identify the ...
BrainScope Receives FDA Clearance for Multi-Modal, Multi-Parameter Concussion Assessment
Ron Klain Joins BrainScope Board of Directors
BETHESDA, MD. November 13, 2018– BrainScope®, a medical neuro-technology company focused on concussion and mild traumatic brain injury (mTBI) assessment, announced today that it has fulfilled orders for over 170 BrainScope One handheld devices and ...
The BrainScope One system provides objective data that helps clinicians answer two key questions in mildly presenting head-injured patients:
The video below focuses on BrainScope One’s successful FDA validation trial providing an overview of algorithm development, trial design and a summary of the validation trial results.
The video below explains one of two of BrainScope One’s EEG-based brain injury assessment capabilities, the Brain Function Index. The BFI compares the patient’s brain electrical activity to that of a comparable non-injured population to objectively ...
The video below explains one of two of BrainScope One’s EEG-based brain injury assessment capabilities, the Structural Injury Classifier. The SIC provides clinicians with objective results that indicate the likelihood of a structural brain injury ...
Artificial Intelligence and Multi-Modal Capabilitiesto Optimize Personalized Concussion Assessment
August 02, 2018 06:00 AM Eastern Daylight Time
Local News story highlighting BrainScope One.
By Eric Mandel
An Economic and Actuarial Model Demonstrates Substantial Cost Benefit to Health Insurers and Patients
Read full white paper here: BrainScope One Economic Analyzer Model White Paper
BETHESDA, MD May 31, 2018 – BrainScope, a medical neurotechnology company focused on concussion and mild traumatic brain injury (mTBI) assessment, announced today the initiation of a large, multi-site clinical research study enrolling subjects ages ...
TALLAHASSEE, Fla., May 18, 2018 /PRNewswire/ -- Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion (mild traumatic brain injury (mTBI)) and other neurological disorders today announced a partnership ...
BrainScope One Provides Objective, Actionable Information for Assessment of Mildly Presenting Head Injured Patients in Urgent Care Centers, Emergency Departments, and Other Settings
Read full white paper here: BrainScope One Urgent Care ED Diversion White Paper – May 2018
BETHESDA, MD. APRIL 30, 2018 – BrainScope announced today the release of a white paper authored by physicians at Washington University Barnes Jewish Medical Center in St. Louis, which demonstrated that the FDA-cleared BrainScope One had the ...
Read full white paper here: Washington University Emergency Department White Paper
Use of the Brainscope device allows providers to quickly and accurately tell if a patient has a serious head injury or not—saving them time and money if they do not have to go to the emergency room.
Startups attract funding to expand sales of tests, tools to detect andmanage brain injuries and illnesses
BETHESDA, MD. September 7, 2017 – BrainScope Company, Inc., the medical neurotechnology company which created the first FDA-cleared handheld medical device, BrainScope One, for assessment of the full spectrum of traumatic brain injury, announced it ...
BETHESDA, MD. August 30, 2017 – BrainScope Company, Inc., the medical neurotechnology company which created the first FDA-cleared handheld medical device for assessment of the full spectrum of traumatic brain injury, today announced it has completed ...
NEW YORK, July 26, 2017 /PRNewswire/ -- The Galien Foundation announced today the 2017 11th Annual Prix Galien USAAward Nominees. Counted among the global health innovation industry's most prized honors, the Prix Galien Award recognizes outstanding ...
BETHESDA, MD. July 10, 2017 – BrainScope Company, Inc. today announced that it has received the Frost & Sullivan 2017 Best Practices Award for New Product Innovation in the Traumatic Brain Injury Assessment Solutions Market.
FDA-Cleared BrainScope One Provides Proprietary, Objective EEG-Based Biomarker for Brain Injury, Including Concussion
Over 1 Million CT Scans Could Be Eliminated Annually in the U.S. by Incorporating BrainScope One into Standard Clinical Practice
BETHESDA, MD. May 23, 2017 – BrainScope Company, Inc. today announced the results of a study spanning over six years demonstrating that sports-related concussions can be objectively assessed using BrainScope’s proprietary electroencephalography ...
BrainScope to Showcase New-to-Market Medical Technology atMomentum 2017: UCAOA Urgent Care Convention and Expo
Peer-Reviewed Publication Demonstrates BrainScope’s Ahead 300 Significantly Improves Prediction of TBI Beyond Standard Clinical Risk Factors Used Today
Likelihood of CT+ vs. CT- Is One Component of the Ahead 300’s Configurable Panel of Capabilities for Mild Head Injury Assessment
In 2013, GE and the NFL teamed up to launch the GE-NFL Head Health Initiative, a four-year, $60 million collaboration to accelerate diagnosis and improve treatment for traumatic brain injury.
Ahead 300 Offers Objective, Configurable Panel of Capabilities at the Point of Care
DISCLAIMER: The Ahead 300 is intended to be used in Emergency Departments, Urgent Care Centers, Clinics and other environments where trained medical professionals and practitioners practice medicine under the direction of a physician.
Panel of Multi-Modal Capabilities Will Aid Physicians With Their Clinical Diagnosis of Head-Injured Patients
A startup says its technology can serve as an objective concussion test. The challenge is convincing people it works.
BETHESDA, MD – May 12, 2016 – BrainScope Company, Inc., a privately held neurotechnology company with an initial focus on traumatic brain injury (TBI) and concussion ...
Contact: Eric HoffmanP: (202) 585-2808E: email@example.com
The Super Bowl shows the NFL is more popular than ever, but the game could change in fundamental ways because of mounting public concerns over head injuries.
BETHESDA, MD. November 23, 2015 – BrainScope Company, Inc., a privately held neurotechnology company with an initial focus on traumatic brain injury (TBI) and concussion assessment, announced today that Michael Singer, Chief Executive Officer, will ...
In recent years, the National Football League has become more and more vigilant about prevention, assessment, and treatment of concussions and head injuries among players.
A Bethesda technology company owned in part by Steve Case’s Revolution LLC gained yardage this week in its bid to help the National Football League and other sports organizations diagnose traumatic brain injuries.
GE NFL Head Health Challenge I Final Award to be Used to Develop Sports Concussion Product for High School Students
Using Commercial Smartphone Technology, Second-Generation System Offers Objective Assessment of Mildly-Presenting Head Trauma Patients
Rapid Response, Non-Invasive, Non-Radiation Emitting Handheld System Offers Objective Assessment of Mildly-Presenting Head Trauma Patients
BrainScope® Company, Inc. was featured in the October issue of GE's healthymagination "Brain Trust" e-magazine. To read the complete article, click on the following graphical link and skip to page 12 of the magazine.
VentureWire, Brian Gormley Sept. 30, 2014, (c) 2014 Dow Jones & Co. Inc.
In Partnership with DOD, BrainScope Advances Development of Traumatic Brain Injury and Concussion Assessment Capabilities
By Robbie Couch
Study Supports the Potential of BrainScope Technology to be an Important Adjunct to Assessment of Traumatic Brain Injury in the Emergency Department
From Maryland Department of Commerce
Traumatic Brain Injury / Concussion Company Receives Certification for Medical Device Design and Manufacturing Quality Systems
Collaboration with Purdue University’s Neurotrauma Group Will Study Mechanisms of Injury for Concussion in Athletes
Study Suggests the Potential of BrainScope Technology to be an Important Adjunct to
Company Recognized For Its Work on Traumatic Brain Injury / Concussion
Announces First InvestMaryland Investment; Governor Launches $300,000 InvestMaryland Challenge Business Plan Competition
BrainScope to Develop Traumatic Brain Injury/Concussion Assessment Capability on a Smartphone
New Studies Suggest the Potential of BrainScope Technology to be an Objective Indicator of Brain Injury, Recovery and Readiness to Return to Sports
Daniel J. Moore, President and CEO of Cyberonics, Joins Board of Directors
Bethesda-based Company Recently Awarded $7.5M Department of Defense Contract
Company Focusing On Point of Care Technology For Assessment of TBI / Concussion
Company to Embark on Pivotal U.S. Prospective Clinical Trial
Findings suggest the potential of BrainScope technology to aid in the triage of patients suspected of head injury in an acute settingfor the assessment of traumatically induced brain injuries
Study supports potential utility of BrainScope technology in developmentfor the assessment of traumatically induced brain injuries
Company Also Announces Formation of Medical Advisory Board
Technology Records and Displays Brain Activity at Initial Point of Care
Please contact us with additional questions at CustomerCare@BrainScope.com or 1-855-927-2461